Features

On 24 September, the United Nations convened in New York for its annual General Assermbly. Dr Christian Rommel, Roche´s Global Head of Pharma...

Steve Rothberg was blindsided by an AML diagnosis that progressed rapidly with little warning. Ten years later, he discusses his outlook and...

Patrick Connor, VP and Global Franchise Head, Tumor Drivers and Resistance Mechanisms, at AstraZeneca, discusses his company’s role in the Lung...

FDA activity has fallen under Donald Trump, with the number of warning letters issued by the regulator dropping by a third since the President...

Charlotte Walker-Osborn, Partner and International Technology Sector Head and Nabil Asaad, Senior Associate, Intellectual Property Law Group –...

“What we believe is objective science and truth at any one moment can be proven to be wrong a few years later”

Through the use of Genomenon’s AI-driven Mastermind Genomic Search Engine, the Rare Genomics Institute succeeded where a leading genetics...

Ann Costello, Global Franchise Lead, Centralised Solutions at Roche Diagnostics, discusses the increasing need for a personalised approach to...

Vaila Morrison’s daughter Eilidh was born with the ultra-rare condition KAT6A. As a designer and architect by profession, Vaila told [Pharmafocus...

Patient-reported outcomes measures are an invaluable tool in ensuring that the patient remains in the driving seat when it comes to their own care...